VEGFR2-tuned regenerative peptide with anti-fibrotic guard
Tendon / soft-tissue repair
recovery agonist pocket: ortho · ▲ 0 · seed bank · 2026-05-02 12:35
🎁 Free tier: 3 design runs / 24h per IP. Each run
produces 4 candidates with full Compounding Lab Spec Sheets — no
signup needed.
Have an API key?
Desired effect
Accelerate tendon and ligament repair by promoting angiogenesis and ECM remodeling; favor VEGFR2 / FGFR1 axis or thymosin-beta-4 / CXCR4 mechanism.
Mechanism rationale
This recovery-lane idea targets the mechanism described in the effect statement. Curated from the platform's 22-effect taxonomy.
Novelty basis
Underexplored in the academic + commercial literature, or addressed only by small-molecule programs. Peptide modality offers selectivity advantages.
Strategic value
Lane wedge: recovery. Buyer archetypes include longevity biotechs, metabolic pharma, and performance/wellness brands depending on indication. Run Phase 4 and judge the public-stats output.
Design parameters
| Primary target | (matcher will resolve) |
|---|---|
| Secondary targets | — |
| Binding mode | agonist |
| Pocket mode | ortho |
| Modality hint | 10-15 aa cyclic peptide via head-to-tail or i,i+4 disulfide |